Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kieburtz

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Journal of Neural Transmission. Supplementum|May 21, 1999
Antiglutamate therapies in Huntington's diseaseK Kieburtz
Neurology|February 1, 1994
HIV or zidovudine myopathy?K Kieburtz
Neurology|July 1, 1997
Policies on reporting clinical trials and publishing supplementsK Kieburtz
Neurology|December 17, 1998
Avoiding conflicts of interest: responsibilities of authors, reviewers, and editorsK Kieburtz
Neurology|January 9, 2001
Benefits of COMT inhibitors in levodopa-treated parkinsonian patients: results of clinical trialsK Kieburtz, J Hubble
Neurologic Clinics|August 1, 1989
Neurologic manifestations of human immunodeficiency virus infectionsK Kieburtz, R B Schiffer
Neurology|February 11, 2000
Of mice and men: a model of HIV encephalitisJ C McArthur, K Kieburtz
Experimental Neurology|June 18, 2017
Clinical approaches to the development of a neuroprotective therapy for PDC W Olanow, K Kieburtz, R Katz
AJNR. American Journal of Neuroradiology|January 1, 1993
Efficacy of gadolinium in MR brain imaging of HIV-infected patientsM Tuite, L Ketonen, K Kieburtz, et al.
Acta Neurologica Scandinavica|September 5, 2014
Pooled analysis of phase III with entacapone in Parkinson's diseaseM Kuoppamäki, M Vahteristo, J Ellmén, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of Neural Transmission. Supplementum|May 21, 1999
Antiglutamate therapies in Huntington's diseaseK Kieburtz
Neurology|February 1, 1994
HIV or zidovudine myopathy?K Kieburtz
Neurology|July 1, 1997
Policies on reporting clinical trials and publishing supplementsK Kieburtz
Neurology|December 17, 1998
Avoiding conflicts of interest: responsibilities of authors, reviewers, and editorsK Kieburtz
Neurology|January 9, 2001
Benefits of COMT inhibitors in levodopa-treated parkinsonian patients: results of clinical trialsK Kieburtz, J Hubble
Neurologic Clinics|August 1, 1989
Neurologic manifestations of human immunodeficiency virus infectionsK Kieburtz, R B Schiffer
Neurology|February 11, 2000
Of mice and men: a model of HIV encephalitisJ C McArthur, K Kieburtz
Experimental Neurology|June 18, 2017
Clinical approaches to the development of a neuroprotective therapy for PDC W Olanow, K Kieburtz, R Katz
AJNR. American Journal of Neuroradiology|January 1, 1993
Efficacy of gadolinium in MR brain imaging of HIV-infected patientsM Tuite, L Ketonen, K Kieburtz, et al.
Acta Neurologica Scandinavica|September 5, 2014
Pooled analysis of phase III with entacapone in Parkinson's diseaseM Kuoppamäki, M Vahteristo, J Ellmén, et al.
Pageof 6